BIA
Biondo Investment Advisors Portfolio holdings
AUM
$759M
This Quarter Return
+7.54%
1 Year Return
+16.64%
3 Year Return
+102.11%
5 Year Return
+165.96%
10 Year Return
+637.5%
AUM
$296M
AUM Growth
+$296M
(+5.5%)
Cap. Flow
-$1.05M
Cap. Flow
% of AUM
-0.36%
Top 10 Holdings %
Top 10 Hldgs %
45.09%
Holding
83
New
7
Increased
33
Reduced
28
Closed
6
Top Buys
| 1 |
ABMD
Abiomed Inc
ABMD
|
$4.55M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$3.8M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$3.69M |
| 4 |
Illumina
ILMN
|
$2.62M |
| 5 |
iShares MSCI Brazil ETF
EWZ
|
$1.74M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$8.85M |
| 2 |
JPM.WS
JPMorgan Chase
JPM.WS
|
$6.99M |
| 3 |
iShares MSCI Turkey ETF
TUR
|
$1.89M |
| 4 |
Lockheed Martin
LMT
|
$791K |
| 5 |
Ford
F
|
$772K |
Sector Composition
| 1 | Healthcare | 29.53% |
| 2 | Financials | 12.95% |
| 3 | Energy | 11.42% |
| 4 | Communication Services | 9.65% |
| 5 | Technology | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Intuitive Surgical
ISRG
$170B
| $23.6M | 7.97% | 32,496 -201 | -0.6% | -$146K |
|
2
Mastercard
MA
$538B
| $22.9M | 7.76% | 225,299 +1,670 | +0.7% | +$170K |
|
3
Apple
AAPL
$3.45T
| $15.3M | 5.17% | 135,148 +15,207 | +13% | +$1.72M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $15M | 5.06% | 143,042 +1,105 | +0.8% | +$116K |
|
5
Meta Platforms (Facebook)
META
$1.86T
| $13.5M | 4.55% | 104,950 -5,400 | -5% | -$693K |
|
|
JPM.WS
6
DELISTED
JPMorgan Chase
JPM.WS
| $9.25M | 3.13% | 375,387 -283,940 | -43% | -$6.99M |
|
7
Idexx Laboratories
IDXX
$51.8B
| $9.09M | 3.07% | 80,621 -2,070 | -3% | -$233K |
|
8
JPMorgan Chase
JPM
$829B
| $8.72M | 2.95% | 130,993 +953 | +0.7% | +$63.5K |
|
|
9
Illumina
ILMN
$15.8B
| $8.46M | 2.86% | 46,553 +14,417 | +45% | +$2.62M |
|
10
Schlumberger
SLB
$55B
| $7.61M | 2.57% | 96,799 +459 | +0.5% | +$36.1K |
|
|
BAC.WS.A
11
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
| $7.26M | 2.46% | 1,570,955 +41,875 | +3% | +$193K |
|
12
Diamondback Energy
FANG
$43.1B
| $7.03M | 2.38% | 72,822 +1,492 | +2% | +$144K |
|
13
Bristol-Myers Squibb
BMY
$96B
| $6.79M | 2.3% | 125,920 +1,113 | +0.9% | +$60K |
|
14
Alphabet (Google) Class A
GOOGL
$2.57T
| $5.9M | 1.99% | 7,333 -5 | -0.1% | -$4.02K |
|
15
Pacira BioSciences
PCRX
$1.2B
| $5.58M | 1.89% | 163,073 -1,754 | -1% | -$60K |
|
16
Under Armour
UAA
$2.14B
| $5.29M | 1.79% | 136,695 +5,110 | +4% | +$198K |
|
17
Core Laboratories
CLB
$540M
| $5M | 1.69% | 44,517 +1,760 | +4% | +$198K |
|
18
Chevron
CVX
$324B
| $4.99M | 1.69% | 48,492 +389 | +0.8% | +$40K |
|
19
VF Corp
VFC
$5.91B
| $4.9M | 1.66% | 87,413 +1,731 | +2% | +$97K |
|
|
20
Regeneron Pharmaceuticals
REGN
$61.5B
| $4.61M | 1.56% | 11,470 +9,185 | +402% | +$3.69M |
|
|
ABMD
21
DELISTED
Abiomed Inc
ABMD
| $4.55M | 1.54% | +35,409 | New | +$4.55M |
|
|
22
Ford
F
$46.8B
| $4.23M | 1.43% | 350,543 -63,933 | -15% | -$772K |
|
23
Philip Morris
PM
$260B
| $4.16M | 1.41% | 42,742 -16 | -0% | -$1.56K |
|
|
24
Lockheed Martin
LMT
$106B
| $4.14M | 1.4% | 17,248 -3,298 | -16% | -$791K |
|
25
Verizon
VZ
$186B
| $4.03M | 1.36% | 77,498 -146 | -0.2% | -$7.59K |
|